Rock Creek Pharmaceuticals, Inc.(Other OTC/NBB : STSI)
STSI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||-1.81%||175.59||0.7%||$1405.98m|
|BMY||Bristol-Myers Squibb Co.||-1.52%||77.03||1.0%||$1169.89m|
|MRK||Merck & Co., Inc.||-1.02%||92.05||0.7%||$1097.17m|
|LLY||Eli Lilly & Co.||-1.98%||295.43||1.1%||$859.74m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||0.09%||141.90||0.0%||$438.60m|
|HZNP||Horizon Therapeutics Plc||-4.82%||88.42||5.4%||$193.67m|
|NVO||Novo Nordisk A/S||-2.61%||103.56||0.1%||$171.61m|
Rock Creek Pharmaceuticals, Inc. is an early stage life science company, which engages in the discovery, development, and commercialization of new drugs, formulations, and compounds that provide therapies for chronic and acute inflammatory diseases. It focuses on small molecule therapeutics that exhibit anti-inflammatory pharmacological characteristics. The company was founded by Jonnie R. Williams, Sr. on June 24, 1985 and is headquartered in Sarasota, FL.